Osage Partners related stories
All articles and analysis
Fund Briefs: Updates on Freestyle, Ignition, Amplify and Osage, among othersFreestyle nears $40M target; Ignition scales back; and Amplify launches
Osage Venture Partners Closes Fund III Above TargetOsage Venture Partners has closed Osage Venture Partners III, exceeding its target fund size by 10 percent to reach $66 million. Osage Venture Partners III will continue with the same strategy for Osage Venture Partners II, investing exclusively in early stage enterprise software companies in the mid-Atlantic region.
- Cardioxyl Raises Series B Led By OrbiMed
Cardioxyl Pharmaceuticals has secured $28 million in a Series B financing led by OrbiMed Advisors. New investor Osage University Partners joined OrbiMed and returning investors New Enterprise Associates and The Aurora Funds in the financing.
- Mirna Therapeutics Closes $34.5M
Mirna Therapeutics Inc., a biopharmaceutical company developing therapeutics in cancer, has raised a $34.5 million Series C financing. Sofinnova Ventures led the round, with participation from investors including New Enterprise Associates, Pfizer Ventures, Osage University Partners, and Correlation Ventures.
- NXT Capital Backs Clinipace Worldwide's Acquisition of Paragon Biomedical
NXT Capital’s venture finance group has provided financing to support Clinipace Worldwide’s acquisition of Paragon Biomedical. Digital contract research organization Clinipace is headquartered in Morrisville, North Carolina and is backed by Morgan Stanley Expansion Capital, Hatteras Venture Partners, Brooke Private Equity, Osage Venture Partners and Mario Family Partners.
Data Report of the Week: Health Insurance Was Hot Area for VCs Before SCOTUS RulingAt least 11 companies in the health services space have raised VC funding or were acquired in recent months
- Amid Bankruptcies, Solar Also Seeing Interest: UPDATED
Mitt Romney’s campaign jaunt last week to Solyndra’s shuttered headquarters and Konarka's Chapter 7 filing drew attention to the solar industry’s most high-profile failures. But a look at recent funding data indicates that, if anything, venture investors in the solar sector are still pretty bullish.